CN1914191A — 4－(4－甲基哌嗪－1－基甲基)－n－[4－甲基－3－(4－吡啶－3－基)嘧啶－2－基氨基)苯基]－苯甲酰胺的盐形式
Assigned to Novartis AG · Expires 2007-02-14 · 19y expired
What this patent protects
本发明涉及4－[(4－甲基－1－哌嗪基)甲基]－N－[4－甲基－3－[[4－(3－吡啶基)－2－嘧啶基]氨基]苯基]－苯甲酰胺的酸加成盐，其选自酒石酸盐，如(D)(－)酒石酸盐或(L)(+)酒石酸盐、盐酸盐、柠檬酸盐、苹果酸盐、富马酸盐、琥珀酸盐、苯甲酸盐、苯磺酸盐、双羟萘酸盐、甲酸盐、丙二酸盐、1，5－萘二磺酸盐、水杨酸盐、环己烷氨基磺酸盐、乳酸盐、扁桃酸盐、含水戊二酸盐、己二酸盐、方酸盐、香草酸盐、草酰乙酸盐、抗坏血酸盐和硫酸盐。
USPTO Abstract
本发明涉及4－[(4－甲基－1－哌嗪基)甲基]－N－[4－甲基－3－[[4－(3－吡啶基)－2－嘧啶基]氨基]苯基]－苯甲酰胺的酸加成盐，其选自酒石酸盐，如(D)(－)酒石酸盐或(L)(+)酒石酸盐、盐酸盐、柠檬酸盐、苹果酸盐、富马酸盐、琥珀酸盐、苯甲酸盐、苯磺酸盐、双羟萘酸盐、甲酸盐、丙二酸盐、1，5－萘二磺酸盐、水杨酸盐、环己烷氨基磺酸盐、乳酸盐、扁桃酸盐、含水戊二酸盐、己二酸盐、方酸盐、香草酸盐、草酰乙酸盐、抗坏血酸盐和硫酸盐。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.